The Norwegian Cancer Society (NCS) celebrates its 75th anniversary in 2013, and in this year of jubilee the record-breaking amount of 160 mill NOK is distributed to in total 121 national research project, spread among 12 different institutions throughout the country. The largest amount goes to Oslo University Hospital, which has been given 73 mill NOK, followed by the University in Oslo (35 mill) and Bergen (24 mill). 50 OUS research projects have been granted support.
The NCS provides approximately 25 per cent of all direct funding for cancer research in Norway, thus contributing to promoting a research environment of top international standard in the country.
From major journals, first or last author from the Institute for Cancer Research
Induction of neoantigen-reactive T cells from healthy donors
Nat Protoc (in press)
Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy
Ann Oncol (in press)
GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells
Haematologica, 104 (5), e229